Oxford Nanopore
Pre-clinicalDiscover a new generation of molecular sensing technology which offers short to ultra-long native DNA and RNA reads.
Founded
2005
Focus
Genetics & GenomicsDiagnostics
About
Discover a new generation of molecular sensing technology which offers short to ultra-long native DNA and RNA reads.
Funding History
8Total raised: $1.2B
IPO$484MUndisclosedSep 30, 2021
Series G$109MIP GroupJun 15, 2020
Series F$195MGICJun 15, 2018
Series E$140MGICJun 15, 2017
Company Info
TypePrivate
Founded2005
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile